EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C44H69NO12 |
| Net Charge | 0 |
| Average Mass | 804.031 |
| Monoisotopic Mass | 803.48198 |
| SMILES | C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC |
| InChI | InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1 |
| InChIKey | QJJXYPPXXYFBGM-LFZNUXCKSA-N |
| Roles Classification |
|---|
| Biological Roles: | bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Application: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tacrolimus (anhydrous) (CHEBI:61049) has role bacterial metabolite (CHEBI:76969) |
| tacrolimus (anhydrous) (CHEBI:61049) has role immunosuppressive agent (CHEBI:35705) |
| tacrolimus (anhydrous) (CHEBI:61049) is a macrolide lactam (CHEBI:145565) |
| Incoming Relation(s) |
| tacrolimus hydrate (CHEBI:61057) has part tacrolimus (anhydrous) (CHEBI:61049) |
| IUPAC Name |
|---|
| (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone |
| INN | Source |
|---|---|
| tacrolimus | KEGG DRUG |
| Synonyms | Source |
|---|---|
| 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | PDBeChem |
| (−)-FK 506 | ChemIDplus |
| FK 506 | KEGG COMPOUND |
| FK506 | KEGG COMPOUND |
| FK506 | KEGG COMPOUND |
| tacrolimus | ChemIDplus |
| Brand Name | Source |
|---|---|
| Prograf | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3647477 | Reaxys |
| Reaxys:8821611 | Reaxys |
| CAS:104987-11-3 | KEGG COMPOUND |
| CAS:104987-11-3 | ChemIDplus |
| CAS:104987-11-3 | KEGG DRUG |